Gynesonics Logo.jpg
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
January 02, 2024 11:13 ET | Gynesonics
Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids
Gynesonics Logo.jpg
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 02, 2023 09:41 ET | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics Logo.jpg
CORRECTION – Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 01, 2023 20:08 ET | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics Logo.jpg
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
November 01, 2023 16:00 ET | Gynesonics
Gynesonics Announces $67M Financing to Expand Commercialization of Sonata® Procedure
Gynesonics Logo.jpg
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
October 25, 2023 16:07 ET | Gynesonics
Gynesonics is pleased to announce that its Sonata Procedure has been used to treat over 1,000 women in the United States in 2023
Gynesonics Logo.jpg
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
October 17, 2023 12:00 ET | Gynesonics
Gynesonics' Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately 6,500 women globally.
Gynesonics Logo.jpg
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids is Now Covered by UnitedHealthcare
August 01, 2023 15:02 ET | Gynesonics
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is...
Skip Baldino
Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization
April 11, 2023 12:00 ET | Gynesonics
REDWOOD CITY, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids,...